TABLE 4.
Radiation Dosing and Estimated Radiation-Induced Cancers in Non-ASIR and ASIR Groups
| Non-ASIR | ASIR | ||
|---|---|---|---|
| CT C/A/P | Effective dose, mSv | 19.8 | 17.1 |
| Excess cases of solid cancers in male patients per 100,000 exposed* |
160 (80–320) | 136 (68–544) | |
| Excess cases of solid cancers in female patients per 100,000 exposed* |
260 (138–500) | 221 (117–425) |
With 95% subjective confidence intervals in parenthesis.